Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracellular methotrexate measurements to predict toxicity during high-dose methotrexate therapy
NL-OMON24644Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in central nervous system lymphoma and acute lymphoblastic leukemia (ALL), sponsored by Erasmus MC. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
methotrexate
03
Conditions
central nervous system lymphomaacute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON24644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24644.